Newsfeeds - Spark Newswire

3 minute read

News

Arbutus Announces 2022 Corporate Objectives And Provides Financial Update

Today, 9:16 PM

Arbutus Biopharma Corporation (NASDAQ:ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced its

ABUS

1 minute read

Arbutus Biopharma Shares Move Higher; Traders Circulate Patent Pundit Tweet Mentioning Stock. BZ NOTE: Patent Pundit Is Not A Reliable Source

By Benzinga Newsdesk

Today, 9:16 PM

https://twitter.com/PunditPatent/status/1478426880206589952

ABUS

3 minute read

25 Stocks Moving in Monday’s Pre-Market Session

By Lisa Levin

Today, 9:16 PM

Gainers Society Pass Incorporated (NASDAQ: SOPA) rose 68% to $5.59 in pre-market trading after the company reported addition to the Russell 2000 Index.

ABUS

1 minute read

Legal
News

BZ NOTE: Arbutus US Patent & Trademark Office Abstract Dated Dec. 7, 2021

By Benzinga Newsdesk

Today, 9:16 PM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=arbutus&OS=arbutus&RS=arbutus

ABUS

1 minute read

Legal
News

Arbutus Shares Spike To Session High Following Circulation Of Dec. 7-Dated US Patent & Trademark Office Abstract For Co.’s ‘Sterically hindered amines’

By Benzinga Newsdesk

Today, 9:16 PM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=arbutus&OS=arbutus&RS=arbutus

ABUS

1 minute read

Why Arbutus Biopharma Shares Are Rising

By Henry Khederian

Today, 9:16 PM

Arbutus Biopharma Corp (NASDAQ: ABUS) shares are trading higher after the company announced it received a $40M upfront payment from Qilu to commercialize AB-729 in Asia.

ABUS

1 minute read

Watching Arbutus Biopharma; Traders Circulate TipRanks Report ‘Keep on Buying Arbutus Stock Before It Jumps 80%, Says Analyst’

By Benzinga Newsdesk

Today, 9:16 PM

https://blog.tipranks.com/keep-on-buying-arbutus-stock-before-it-jumps-80-says-analyst/

ABUS

1 minute read

‘5 Penny Stocks To Buy According To Analysts & Targets Up To 341%’ -PennyStocks.com Article Highlighting Idera, Biofrontera, SPI Energy, ReWalk, Arbutus

By Benzinga Newsdesk

Today, 9:16 PM

https://pennystocks.com/featured/2021/12/08/5-penny-stocks-to-buy-according-to-analysts-targets-341/

ABUS

4 minute read

61 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:16 PM

Gainers

ABUS

3 minute read

Mid-Afternoon Market Update: Dow Rises Over 100 Points; CTI BioPharma Shares Plummet

By Lisa Levin

Today, 9:16 PM

Toward the end of trading Wednesday, the Dow traded up 0.39% to 34,617.2 while the NASDAQ climbed 0.17% to 15,564.73. The S&P also rose, gaining 0.68% to 4,597.96.

ABUS